☰

Rudolf Mihalik - Publications

Affiliations: 
Semmelweis Egyetem, Hungary 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Pálóczi K, Pócsik É, Mihalik R, Benczur M, Demeter J, Solti V, Petrányi G, Hollan SR. Detection of Activation Antigens on Chronic Lymphocytic Leukaemia Cells. Leukemia & Lymphoma. 3: 31-6. PMID 27457195 DOI: 10.3109/10428199009050972  0.375
2012 Barna G, Sebestyén A, Dunai ZA, Csernus B, Mihalik R. Heparin can liberate high molecular weight DNA from secondary necrotic cells. Cell Biology International. 36: 1281-6. PMID 22953972 DOI: 10.1042/Cbi20120189  0.456
2012 Dunai ZA, Imre G, Barna G, Korcsmaros T, Petak I, Bauer PI, Mihalik R. Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. Plos One. 7: e41945. PMID 22860037 DOI: 10.1371/Journal.Pone.0041945  0.407
2011 Dunai Z, Bauer PI, Mihalik R. Necroptosis: biochemical, physiological and pathological aspects. Pathology Oncology Research : Por. 17: 791-800. PMID 21773880 DOI: 10.1007/S12253-011-9433-4  0.413
2011 Kun E, Mendeleyev J, Kirsten E, Hakam A, Kun AM, Fekete A, Bauer PI, Dunai Z, Mihalik R. Regulation of malignant phenotype and bioenergetics by a Ï€-electron donor-inducible mitochondrial MgATPase. International Journal of Molecular Medicine. 27: 181-6. PMID 21125212 DOI: 10.3892/Ijmm.2010.567  0.308
2011 Barna G, Mihalik R, Timár B, Tömböl J, Csende Z, Sebestyén A, Bödör C, Csernus B, Reiniger L, Peták I, Matolcsy A. ROR1 expression is not a unique marker of CLL. Hematological Oncology. 29: 17-21. PMID 20597086 DOI: 10.1002/Hon.948  0.385
2007 Schwab R, Micsik T, Szokolóczi O, Schafer E, Tihanyi B, Tihanyi T, Kupcsulik P, Diófalvi K, Mersich T, Besznyak I, Zarand A, Mihalik R, Sarkadi B, Kéri G, Pap A, et al. Functional evaluation of multidrug resistance transporter activity in surgical samples of solid tumors. Assay and Drug Development Technologies. 5: 541-50. PMID 17767422 DOI: 10.1089/Adt.2007.067  0.344
2007 Imre G, Dunai Z, Petak I, Mihalik R. Cystein cathepsin and Hsp90 activities determine the balance between apoptotic and necrotic cell death pathways in caspase-compromised U937 cells. Biochimica Et Biophysica Acta. 1773: 1546-57. PMID 17707089 DOI: 10.1016/J.Bbamcr.2007.07.003  0.454
2006 Nagy K, Székely-Szüts K, Izeradjene K, Douglas L, Tillman M, Barti-Juhász H, Dominici M, Spano C, Luca Cervo G, Conte P, Houghton JA, Mihalik R, Kopper L, Peták I. Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria. Pathology Oncology Research : Por. 12: 133-42. PMID 16998592 DOI: 10.1007/Bf02893359  0.406
2005 Barna G, Sebestyén A, Weischede S, Peták I, Mihalik R, Formelli F, Kopper L. Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cells. Anticancer Research. 25: 4179-85. PMID 16309214  0.404
2005 Felföldi B, Imre G, Igyártó B, Iván J, Mihalik R, Lackó E, Oláh I, Magyar A. In ovo vitelline duct ligation results in transient changes of bursal microenvironments. Immunology. 116: 267-75. PMID 16162275 DOI: 10.1111/J.1365-2567.2005.02221.X  0.401
2005 Mihalik R, Imre G, Petak I, Szende B, Kopper L. Cathepsin B-independent abrogation of cell death by CA-074-OMe upstream of lysosomal breakdown. Cell Death and Differentiation. 11: 1357-60. PMID 15297886 DOI: 10.1038/Sj.Cdd.4401493  0.363
2000 Sebestyén A, Tótth A, Mihalik R, Szakács O, Paku S, Kopper L. Syndecan-1-dependent homotypic cell adhesion in HT58 lymphoma cells. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 21: 349-57. PMID 11006575 DOI: 10.1159/000030140  0.431
2000 Amin F, Bowen ID, Szegedi Z, Mihalik R, Szende B. Apoptotic and non-apoptotic modes of programmed cell death in MCF-7 human breast carcinoma cells Cell Biology International. 24: 253-260. PMID 10816327 DOI: 10.1006/Cbir.2000.0495  0.425
2000 Nagy E, Mihalik R, Hrabák A, Vértesi C, Gergely P. Apoptosis inhibitory effect of the isothiourea compound, tri-(2-thioureido-S-ethyl)-amine. Immunopharmacology. 47: 25-33. PMID 10708807 DOI: 10.1016/S0162-3109(99)00183-6  0.351
1999 Mihalik R, Bauer P, Peták I, Krajcsi P, Marton A, Kun E, Kopper L. Interaction of cytocidal drugs and the inhibition of caspase-3 by 3-nitrosobenzamide. International Journal of Cancer. Journal International Du Cancer. 82: 875-9. PMID 10446456 DOI: 10.1002/(Sici)1097-0215(19990909)82:6<875::Aid-Ijc17>3.0.Co;2-T  0.441
1999 Sebestyén A, Berczi L, Mihalik R, Paku S, Matolcsy A, Kopper L. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas. British Journal of Haematology. 104: 412-9. PMID 10050727 DOI: 10.1046/J.1365-2141.1999.01211.X  0.383
1999 Mihalik R, Sebestyén A, Barna G, Bauer P, Kopper L. Death receptors in etoposide treated lymphoma cells European Journal of Cancer. 35: S104. DOI: 10.1016/S0959-8049(99)80798-9  0.397
1998 Sebestyén A, Kovalszky I, Mihalik R, Gallai M, Bocsi J, László E, Benedek S, Sréter L, Kopper L. Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia. European Journal of Cancer (Oxford, England : 1990). 33: 2273-7. PMID 9470818 DOI: 10.1016/S0959-8049(97)00248-7  0.403
1997 Mihalik R, Uher F, Peták, Sebestyén A, Kopper L. Regulation of Differentiation, Proliferation and Drug-Induced Apoptosis in HT58 Lymphoma Cells. Pathology Oncology Research : Por. 3: 100-105. PMID 11173634 DOI: 10.1007/Bf02907802  0.441
1997 Marton A, Mihalik R, Bratincsák A, Adleff V, Peták I, Végh M, Bauer PI, Krajcsi P. Apoptotic cell death induced by inhibitors of energy conservation--Bcl-2 inhibits apoptosis downstream of a fall of ATP level. European Journal of Biochemistry / Febs. 250: 467-75. PMID 9428700 DOI: 10.1111/J.1432-1033.1997.0467A.X  0.381
1996 Mihalik R, Uher F, Pocsik É, Berczi L, Benczur M, Kopper L. Detection of Drug-induced Apoptosis by Flow Cytometry after Alkaline Extraction of Ethanol Fixed Cells. Pathology Oncology Research : Por. 2: 78-83. PMID 11173591 DOI: 10.1007/Bf02893956  0.432
1996 Mihalik R, Kopper L, Benczúr M. Modulation of drug-induced apoptosis in a human B-lymphoma cell line (HT58). Immunology Letters. 48: 17-21. PMID 8847085 DOI: 10.1016/0165-2478(95)02434-4  0.486
1996 Mihalik R, Farkas G, Kopper L, Benczúr M, Faragó A. Possible involvement of protein kinase C-epsilon in phorbol ester-induced growth inhibition of human lymphoblastic cells. The International Journal of Biochemistry & Cell Biology. 28: 925-33. PMID 8811841 DOI: 10.1016/1357-2725(96)00020-9  0.414
1995 Pocsik E, Mihalik R, Penzes M, Loetscher H, Gallati H, Aggarwal BB. Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors Journal of Cellular Biochemistry. 59: 303-316. PMID 8567749 DOI: 10.1002/Jcb.240590303  0.37
1992 Uher F, Alonso ME, Mihalik R, Balogh É, Gergely J. Autocrine Regulation of Murine B Lymphocyte Growth by an IgM Antibody Immunobiology. 185: 292-302. PMID 1452206 DOI: 10.1016/S0171-2985(11)80647-9  0.35
1992 Uher F, Mihalik R, Alonso ME, Gergely J. Down-regulation of murine B lymphocyte growth: arrest of B cells in G1 underlies immunosuppression induced by an IgM antibody. Immunology Letters. 33: 255-261. PMID 1428000 DOI: 10.1016/0165-2478(92)90070-5  0.384
1991 Pócsik E, Mihalik R, Réti M, Gyódi E, Pálóczi K, Mayer K, Kassai M, Herold M, Huber C, Petrányi GG. Differences in non-MHC restricted cytotoxic activities of human peripheral blood lymphocytes after transfusion with allogeneic leukocytes or platelets possessing class I and/or class II MHC molecules. Immunobiology. 182: 22-31. PMID 1983002 DOI: 10.1016/S0171-2985(11)80580-2  0.306
1990 Kopper L, Bankfalvi A, Mihalik R, Glant TT, Timar J. Proteoglycan-targeted antibodies as markers on non-Hodgkin lymphoma xenografts Cancer Immunology, Immunotherapy. 32: 137-142. PMID 2289206 DOI: 10.1007/Bf01754211  0.36
Show low-probability matches.